Jun 30, 2021
In this episode, we hear the argument in favor of the new Alzheimer's drug, Aducanumab (Aduhelm). Dr. Marwan Sabbagh is a clinical and research leader at the Cleveland Clinic's Lou Ruvo Center for Brain Health. He was a doctor that saw patients in one of the trials that led to the FDA's Accelerated...
Jun 14, 2021
This week we will do almost a Part 2 from the last episode with Drs Dale Bredesen and Kat Toups. In that episode, we featured recently released results data on MedArchive from a clinical trial in which 84% of 25 patients with early Alzheimer's Disease and Mild Cognitive Impairment improved with a Precision Medicine...
Jun 1, 2021
Our guests today are Drs Kat Toups & Dale Bredesen.
Link to the study results just released online:
https://www.medrxiv.org/content/10.1101/2021.05.10.21256982v1.full.pdf
Important to note, this has not yet been peer-reviewed yet.
25 participants in this group, underwent a 9-month trial.
21 people improved, 1 person...